198 related articles for article (PubMed ID: 22000800)
21. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
[TBL] [Abstract][Full Text] [Related]
22. Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection.
Zhang X; Gu J; Cao L; Li N; Ma Y; Su Z; Ding G; Chen L; Xu X; Xiao W
Mol Biosyst; 2014 Oct; 10(10):2517-25. PubMed ID: 25000319
[TBL] [Abstract][Full Text] [Related]
23. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy.
Sucher NJ
Epilepsy Behav; 2006 Mar; 8(2):350-62. PubMed ID: 16455305
[TBL] [Abstract][Full Text] [Related]
24. [Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].
Wang J; Lu F; Dong H; Gong Y; Xu L; Zou X; Chen G
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2271-6. PubMed ID: 22097345
[TBL] [Abstract][Full Text] [Related]
25. [A method for predicting activity of traditional Chinese medicine based on quantitative composition-activity relationship of neural network model].
Zhao XP; Fan XH; Yu J; Cheng YY
Zhongguo Zhong Yao Za Zhi; 2004 Nov; 29(11):1082-5. PubMed ID: 15656145
[TBL] [Abstract][Full Text] [Related]
26. [Recent progress on anti-HIV research of traditional Chinese medicine and components].
Liu ZM; Yang YS; Wang XL; Wen RX
Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(21):1753-8. PubMed ID: 17260784
[TBL] [Abstract][Full Text] [Related]
27. Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines.
Huang X; Kong L; Li X; Chen X; Guo M; Zou H
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):71-84. PubMed ID: 15556489
[TBL] [Abstract][Full Text] [Related]
28. [Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets].
Hao HP; Zheng CN; Wang GJ
Yao Xue Xue Bao; 2009 Mar; 44(3):270-5. PubMed ID: 19449523
[TBL] [Abstract][Full Text] [Related]
29. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
[TBL] [Abstract][Full Text] [Related]
30. In silico search for multi-target therapies for osteoarthritis based on 10 common Huoxue Huayu herbs and potential applications to other diseases.
Zheng CS; Zhuang ZQ; Xu XJ; Ye JX; Ye HZ; Li XH; Wu GW; Xu HF; Liu XX
Mol Med Rep; 2014 Mar; 9(3):857-62. PubMed ID: 24452288
[TBL] [Abstract][Full Text] [Related]
31. Methodology of pharmacodynamic evaluation on Chinese herbal medicine based on syndrome differentiation.
Lu AP; Liu XW; Ding XR
Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):501-4. PubMed ID: 19583928
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice.
He K; Li X; Chen X; Ye X; Huang J; Jin Y; Li P; Deng Y; Jin Q; Shi Q; Shu H
J Ethnopharmacol; 2011 Oct; 137(3):1135-42. PubMed ID: 21798327
[TBL] [Abstract][Full Text] [Related]
33. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
Yamabe N; Kim HY; Kang KS; Zhao Q; Matsumoto K; Yokozawa T
J Ethnopharmacol; 2010 Jun; 129(3):299-305. PubMed ID: 20363309
[TBL] [Abstract][Full Text] [Related]
34. Phytochemical databases of Chinese herbal constituents and bioactive plant compounds with known target specificities.
Ehrman TM; Barlow DJ; Hylands PJ
J Chem Inf Model; 2007; 47(2):254-63. PubMed ID: 17381164
[TBL] [Abstract][Full Text] [Related]
35. Chemogenomics approaches to rationalizing the mode-of-action of traditional Chinese and Ayurvedic medicines.
Mohd Fauzi F; Koutsoukas A; Lowe R; Joshi K; Fan TP; Glen RC; Bender A
J Chem Inf Model; 2013 Mar; 53(3):661-73. PubMed ID: 23351136
[TBL] [Abstract][Full Text] [Related]
36. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
[TBL] [Abstract][Full Text] [Related]
37. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
38. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
Bagger JI; Knop FK; Holst JJ; Vilsbøll T
Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
[TBL] [Abstract][Full Text] [Related]
39. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
40. [Study on combination components and effectiveness of Chinese traditional herbal formulas].
Wang J; Guo LL; Wang YY
Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):5-9. PubMed ID: 16548156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
